The impact of cell penetrating peptides in prospective cancer therapy: a review

The impact of cell penetrating peptides in prospective cancer therapy: a review

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Бібліографічні деталі
Автор:	Nashrah, Zannatul
Інші автори:	Sabrina, Sharmin
Формат:	Дисертація
Мова:	English
Опубліковано:	Brac University 2023
Предмети:	Cancer Cancer penetrating peptides Drug delivery Oligonucleotides siRNA Therapies CPP Cancer > Treatment Multidrug delivery.
Онлайн доступ:	http://hdl.handle.net/10361/22021

Схожі ресурси

A review on carbon nanotube: a new era in cancer diagnosis & therapy
за авторством: Parvez, Safi
Опубліковано: (2023)

A review on RNAi technology and its therapeutic potential in Cancer
за авторством: Mahaleka, Aarshi
Опубліковано: (2024)

Breast cancer therapy through Liposomal drug delivery system
за авторством: Ome, Nusrat Jahan
Опубліковано: (2024)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
за авторством: Nahar, Kamrun
Опубліковано: (2023)

A review on the recent advancements on nanoparticles drug delivery approaches in anti-cancer treatment
за авторством: Hoque, Syeda Mehren
Опубліковано: (2024)

A review on targeted therapies for lung cancer
за авторством: Ashraf, Anushey
Опубліковано: (2023)

A computational approach to design putative potential siRNAs for silencing the nucleoprotein and surface glycoprotein gene of MARV
за авторством: Suraiya, Tasnia Iffat
Опубліковано: (2023)

RIPK pathway, as a potential target, for cancer treatment - a review
за авторством: Jahan, Nusrat
Опубліковано: (2024)

Natural products and their combinatory effects in breast cancer treatment
за авторством: Siddique, Md. Ayman
Опубліковано: (2021)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
за авторством: Kamal, Tasnova
Опубліковано: (2019)

A comprehensive review on drug repurposing in cancer treatment
за авторством: Sarkar, Onusree
Опубліковано: (2024)

Current practice and approaches of immunotherapy in Cancer treatment
за авторством: Khondokar, Faiza
Опубліковано: (2022)

A review of Cell-penetrating peptide mediated drug delivery to the brain
за авторством: Tisha, Zarin Tasnim
Опубліковано: (2024)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
за авторством: Hasan, Amit
Опубліковано: (2024)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
за авторством: Abir, Shifaty Nur
Опубліковано: (2024)

Immunotherapy in the Management of Lung Cancer
за авторством: Tasnim, Humayra
Опубліковано: (2022)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
за авторством: Rahman, Tasnim
Опубліковано: (2024)

Precision medicine in four deadliest Cancers of the world : present practices & future prospects
за авторством: Islam, Ankita
Опубліковано: (2022)

Stem cells as therapeutic carrier in cancer treatment
за авторством: Anika, Mysha Yeasmin
Опубліковано: (2022)

Targeted therapeutic options in the treatment of Breast Cancer
за авторством: Alam, Kazi Tasnuva
Опубліковано: (2022)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
за авторством: Hossain, Safa Binte
Опубліковано: (2019)

Statistics and informatics in molecular cancer research

Epigenetic therapy in cancer
за авторством: Abid, Md. Shadman Ridwan
Опубліковано: (2021)

Recent advancement on breast cancer detection and treatment
за авторством: Rahman, Sanjida
Опубліковано: (2023)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
за авторством: Alam, Tahera
Опубліковано: (2024)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
за авторством: Chakraborty, Anuradha
Опубліковано: (2024)

Targeting BRAFV600E in the treatment of CRC
за авторством: Roja, Mashwiyat Samrin
Опубліковано: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
за авторством: Flora, Sanzida Alam
Опубліковано: (2024)

Biosimilar in lymphoma treatment
за авторством: Tanisha, Mehrin Haque
Опубліковано: (2021)

ক্যান্সার : মৃত্যু অবধারিত নয় /
за авторством: করীম, আবুল বাশার মোহাম্মদ ফজলুল

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
за авторством: Razna, Amrin Islam
Опубліковано: (2019)

A review on potential of PARP inhibitors in the treatment of prostate cancer
за авторством: Islam, Saidul
Опубліковано: (2022)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
за авторством: Muntaha, Habibatul
Опубліковано: (2023)

Palliative care services in cancer treatment: a study of the current scenario in Dhaka
за авторством: Rahman, Qazi Ashrafur
Опубліковано: (2018)

Unlocking the therapeutic potential of RNA: a comprehensive review of RNA-based therapy
за авторством: Ahmad, Rafid Uddin, та інші
Опубліковано: (2024)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
за авторством: Nuha, Nabiha Tahsin
Опубліковано: (2024)

A review paper on Nanotechnology based strategies in the treatment of cancer
за авторством: Rahman, Samia
Опубліковано: (2022)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
за авторством: Rahman, Sanjida
Опубліковано: (2024)

Microneedles in pain management of Cancer
за авторством: Islam, Shafiqul
Опубліковано: (2022)

Cancer risk factors: a critical review
за авторством: Tabassum, Tahsina
Опубліковано: (2017)